← Leaderboards
Maryellen Lynch
Battelle Centers/Pub Hlth Res & Evaluatn
$640,263
Attributed
$640,263
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $374.2K · FY2014–17$500K$375K$250K$125K$0
'14
'15
'16
'17
Funding mix
By agency
NIH$640,263 · 2
By mechanism
N01$640,263 · 2
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Toxic Effect”
- George R Seage · Abt Associates, Inc.$224,114,540
- Peter C Adamson · National Childhood Cancer Foundation$126,756,857
- Gregory H Reaman · National Childhood Cancer Foundation$123,836,183
- Carol Nesel · Westat$116,355,411
- Mary M Horowitz · Medical College Of Wisconsin$90,165,506
- Barney Sparrow · Battelle Memorial Institute$88,494,220
Research focus
Toxic EffectPharmaceutical PreparationsOrganSourceResearch Clinical TestingMalignant NeoplasmsEvaluationAnticancer ActivityIn VitroAnti-Cancer TherapeuticInvestigationTissuesToxicologyContractsAwardMaintenanceCellsCancer TherapyCanis FamiliarisDoseAspartate TransaminaseArchivesAmendmentAnticoagulants
Grant awards (6)
IGF::OT::IGF NExT Mcl-1 NX232-108-172-001 TO#3 Exploratory Tox Study in Dogs Admin Mcl-1 Inhibitor Orally, 8/11/17-12/31/18, Pre-clin Tox & Pharm Study of Drug Dev for Cancer & Other Diseases, HHSN26$116,039
N01 · FY2017 · CA · contact PI
FT11 NIDDK (WA03)$60,052
N01 · FY2016 · CA · contact PI
Exploratory Toxicology Study in Dogs Administered Investigative Drugs Orally Task Order 16$89,937
N01 · FY2015 · CA · contact PI
Task Order 15 Nonclinical Toxicology Study of an investigational agent in development for anticancer therapy$238,693
N01 · FY2014 · CA · contact PI
Task Order 14 Nonclinical Toxicology Study of an investigational agent in development for anticancer therapy$133,021
N01 · FY2014 · CA · contact PI
Nonclinical Toxicology Study of an investigational agent in development for anticancer therapy (Task Order 13)$2,521
N01 · FY2014 · CA · contact PI